Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Some patients experience severe symptoms from gastroparesis, such as nausea, vomiting, and abdominal pain
Contact your GP promptly if you experience: Persistent nausea or vomiting that interferes with eating or drinking adequately Signs of hypoglycaemia (low blood sugar) such as trembling, sweating, confusion, or rapid heartbeat, especially if you're taking Ozempic alongside other diabetes medications Significant unintended weight loss or inability to maintain adequate nutrition due to reduced appetite Symptoms of dehydration including dark urine, dizziness, or reduced urination Right upper abdominal pain which could indicate gallbladder problems New or worsening vision problems , particularly if you have pre-existing diabetic retinopathy Arrange a routine appointment to discuss: Changes in eating patterns that concern you or affect your quality of life Difficulty maintaining a balanced diet due to altered food preferences Questions about adjusting your dose if side effects are troublesome Contraception needs, as Ozempic should be stopped at least two months before planned pregnancy Your GP may adjust your Ozempic dose, review your overall diabetes management plan, or refer you to specialist services if needed
For those considered overweight or having obesity, losing 5% or more of initial weight is linked to lessening cardiometabolic disease risk, with reductions in blood pressure, LDL cholesterol, triglycerides, and glycemia
Absent of sugars and starches, keto diets tend to come with eating more protein anyway
They mimic the natural hormone GLP-1, which: Slows gastric emptying (so you feel full longer) Reduces appetite and food cravings Improves blood sugar control Enhances insulin sensitivity Benefits of GLP-1 Therapy Promotes consistent and gradual weight loss Reduces hunger and emotional eating Helps regulate blood sugar and insulin levels Supports cardiometabolic health Non-stimulant, non-habit-forming Weekly injections with minimal side effects Fully monitored by our medical team Who Is GLP-1 Therapy For
Once-weekly subcutaneous retatrutide administration heightened the risk of gastrointestinal and hypersensitivity incidents, typically non-severe
